Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 2.54 0.14%
NASDAQ 4,095.52 9.29 0.23%
Ticker Volume Price Price Delta
STOXX 50 3,155.81 16.55 0.53%
FTSE 100 6,625.25 41.08 0.62%
DAX 9,409.71 91.89 0.99%
Ticker Volume Price Price Delta
NIKKEI 14,551.20 34.93 0.24%
TOPIX 1,173.56 0.19 0.02%
HANG SENG 22,760.24 64.23 0.28%

Bristol-Myers Squibb to Announce Results for Fourth Quarter, Full Year 2012 on January 24



  Bristol-Myers Squibb to Announce Results for Fourth Quarter, Full Year 2012
  on January 24

Business Wire

NEW YORK -- January 4, 2013

Bristol-Myers Squibb Company (NYSE:BMY) will announce results for the fourth
quarter and full year of 2012 on Thursday, January 24, 2013. During a
conference call at 10:30 a.m. ET on January 24, company executives will review
financial information and will address inquiries from investors and analysts.

Investors and the general public are invited to listen to a live webcast of
the call at http://investor.bms.com or by dialing 913-981-5581, confirmation
code: 8041448. Materials related to the call will be available at the same
website prior to the conference call. A replay of the call will be available
beginning at 2 p.m. ET on January 24 through midnight ET on February 7, 2013.
The replay will also be available through http://investor.bms.com or by
dialing 402-280-9013, confirmation code: 8041448.

About Bristol-Myers Squibb

Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to
discover, develop and deliver innovative medicines that help patients prevail
over serious diseases. For more information, please visit www.bms.com or
follow us on Twitter at http://twitter.com/bmsnews.

Contact:

Bristol-Myers Squibb Company
Media:
Jennifer Fron Mauer, 609-252-6579
jennifer.mauer@bms.com
or
Investors:
John Elicker, 609-252-4611
john.elicker@bms.com
Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement